204 related articles for article (PubMed ID: 2473641)
1. Mast cells, neuropeptides and inflammation.
Church MK; Lowman MA; Rees PH; Benyon RC
Agents Actions; 1989 Apr; 27(1-2):8-16. PubMed ID: 2473641
[No Abstract] [Full Text] [Related]
2. Interaction of neuropeptides with human mast cells.
Church MK; Lowman MA; Robinson C; Holgate ST; Benyon RC
Int Arch Allergy Appl Immunol; 1989; 88(1-2):70-8. PubMed ID: 2468622
[TBL] [Abstract][Full Text] [Related]
3. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli.
Benyon RC; Robinson C; Church MK
Br J Pharmacol; 1989 Jul; 97(3):898-904. PubMed ID: 2474353
[TBL] [Abstract][Full Text] [Related]
4. General anaesthetics induce only histamine release selectively from human mast cells.
Stellato C; Casolaro V; Ciccarelli A; Mastronardi P; Mazzarella B; Marone G
Br J Anaesth; 1991 Dec; 67(6):751-8. PubMed ID: 1722691
[TBL] [Abstract][Full Text] [Related]
5. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin.
Okayama Y; Benyon RC; Lowman MA; Church MK
Allergy; 1994 Apr; 49(4):246-53. PubMed ID: 7518654
[TBL] [Abstract][Full Text] [Related]
7. Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells activated with peptides.
Levi-Schaffer F; Shalit M
Int Arch Allergy Appl Immunol; 1989; 90(4):352-7. PubMed ID: 2482257
[TBL] [Abstract][Full Text] [Related]
8. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung.
Butchers PR; Vardey CJ; Johnson M
Br J Pharmacol; 1991 Nov; 104(3):672-6. PubMed ID: 1724629
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A.
Triggiani M; Cirillo R; Lichtenstein LM; Marone G
Int Arch Allergy Appl Immunol; 1989; 88(1-2):253-5. PubMed ID: 2468619
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of histamine secretion induced by neuropeptides: implications for the relevance of peptide-mast cell interactions in allergy and inflammation.
Pearce FL; Kassessinoff TA; Liu WL
Int Arch Allergy Appl Immunol; 1989; 88(1-2):129-31. PubMed ID: 2468610
[TBL] [Abstract][Full Text] [Related]
11. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion.
Marone G; Cirillo R; Genovese A; Marino O; Quattrin S
Life Sci; 1989; 45(19):1745-54. PubMed ID: 2480501
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenylate cyclase activating polypeptide (PACAP) is localized in human dermal neurons and causes histamine release from skin mast cells.
Odum L; Petersen LJ; Skov PS; Ebskov LB
Inflamm Res; 1998 Dec; 47(12):488-92. PubMed ID: 9892043
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of human intestinal mast cell mediator release in active ulcerative colitis.
Fox CC; Lazenby AJ; Moore WC; Yardley JH; Bayless TM; Lichtenstein LM
Gastroenterology; 1990 Jul; 99(1):119-24. PubMed ID: 1693122
[TBL] [Abstract][Full Text] [Related]
14. Mediator release from human lung mast cell subtypes in chronic bronchitis and emphysema.
van Overveld FJ
Agents Actions; 1989 Apr; 27(1-2):97-100. PubMed ID: 2473645
[TBL] [Abstract][Full Text] [Related]
15. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin.
Cohan VL; Undem BJ; Fox CC; Adkinson NF; Lichtenstein LM; Schleimer RP
Am Rev Respir Dis; 1989 Oct; 140(4):951-4. PubMed ID: 2478059
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells.
Okayama Y; Church MK
Int Arch Allergy Immunol; 1992; 97(3):216-25. PubMed ID: 1375203
[TBL] [Abstract][Full Text] [Related]
18. Study of the effect of some neuropeptides and endogenous opioid peptides on in vitro histamine release from human lung mast cells and peripheral blood basophils.
Miadonna A; Leggieri E; Tedeschi A; Lorini M; Froldi M; Zanussi C
Agents Actions; 1988 Aug; 25(1-2):11-6. PubMed ID: 2461058
[TBL] [Abstract][Full Text] [Related]
19. Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells.
Lowman MA; Benyon RC; Church MK
Br J Pharmacol; 1988 Sep; 95(1):121-30. PubMed ID: 2464382
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin.
Marone G; Columbo M; Galeone D; Guidi G; Kagey-Sobotka A; Lichtenstein LM
Agents Actions; 1986 Apr; 18(1-2):100-2. PubMed ID: 2425566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
